Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis

Journal of Infectious Diseases

Volumn 190, Issue 3, 2004, Pages 605-612

  Lilly, Elizabeth A ^a   Hart, Darrenn J ^a   Leigh, Janet E ^a   Hager, Shannon ^a   McNulty, Kelly M ^a   Mercante, Donald E ^a   Fidel Jr , Paul L ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LA State Univ School of Dentistry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CYTOKINE; RNA;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HELPER CELL; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OROPHARYNX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THRUSH;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HIV SEROPOSITIVITY; HUMANS; OROPHARYNX; RNA, MESSENGER;

EID: 3242774514     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422154     Document Type: Article

References (44)

1. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:354-8.
2. Macher AM. The pathology of AIDS. Public Health Rep 1988; 103:246-54.
3. Greenspan JS, Barr CE, Sciubba JJ, Winkler JR. Oral manifestations of HIV infection: definitions, diagnostic criteria and principles of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992; 73:142-4.
4. Laskaris G, Hadjivassiliou M, Stratigos J. Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med 1992; 21:120-3.
5. Calderone RA, ed. Candida and candidiasis. Washington, DC: ASM Press, 2002.
6. Fichtenbaum CJ, Powderly W. Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. Clin Infect Dis 1998; 26:556-65.
7. Clift RA. Candidiasis in the transplant patient. Am J Med 1984; 77(Suppl 4D):34-8.
8. Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellitus. J Infect Dis 1971; 123:371-7.
9. Dodd CL, Greenspan D, Katz MH, Westenhouse JL, Feigal DW, Greenspan JS. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 1991; 5:1339-43.
10. Leigh JE, Barousse M, Swoboda RK, et al. Candida-specific systemic cell-mediated immune reactivities in HIV-infected persons with and without mucosal candidiaisis. J Infect Dis 2001; 183:277-85.
11. Odds FC. Chronic mucocutaneous candidiosis. In: Odds FC, ed. Candida and candidosis. Baltimore, MD: University Park Press, 1988:104-20.
12. Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 1991; 59:4647-54.
13. Fischer A, Ballet JJ, Griscelli C. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharide antigens present in serum of patients with chronic mucocutaneous candidiasis. J Clin Invest 1978; 62:1005-13.
14. Paterson PY, Semo R, Blumenschein G, Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol 1971; 9:595-602.
15. Reichart PA, Samaranayake LP, Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis 2000; 6:85-91.
16. Imam N, Carpenter CCJ, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990; 89:142-6.
17. Fidel PL Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993; 168:1458-65.
18. Romani L, Puccetti P, Bistoni F, Romagnani S. Biological role of Th cell subsets in candidiasis. In: Romagnani S, ed. Th1 and Th2 cells in health and disease. Farmington, CT: Karger, 1996:114-27.
19. Leigh JE, Steele C, Wormley FL Jr, et al. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:373-80.
20. Steele C, Leigh JE, Swoboda RK, Fidel PL Jr. Growth inhibition of Candida by human oral epithelial cells. J Infect Dis 2000; 182:1479-85.
21. Wozniak KL, Leigh JE, Hager S, Swoboda RK, Fidel PL Jr. A comprehensive study of Candida-specific antibodies in saliva of human immunodeficiency virus-infected persons with oropharyngeal candidiasis. J Infect Dis 2002; 185:1269-76.
22. Myers TA, Leigh JE, Arribas A, et al. Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis. Infect Immun 2003; 71:956-63.
23. + lymphocytes. J Immunol 1995; 154:5273-81.
24. + T lymphocytes from HIV-1 infected individuals. Bol Asoc Med P R 1998; 90:21-6.
25. Deslauriers N, Cote L, Montplaisir S, De Repentigny L. Oral carriage of Candida albicans in murine AIDS. Infect Immun 1997; 65:661-7.
26. + T cells are involved in elimination of Candida albicans from the livers of mice. Mycoses 1997; 40:41-6.
27. Slavinsky J III, Myers T, Swoboda RK, Leigh JE, Hager S, Fidel PL Jr. Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis. Oral Microbiol Immunol 2002; 17:38-43.
28. Patton LL, McKaig RG, Strauss RP, Enron JJ. Oral manifestations of HIV in a southeast USA population. Oral Dis 1998; 4:164-9.
29. Revankar SG, Sanche SE, Dib OP, Caceres M, Patterson TF. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients. AIDS 1998; 12:2511-3.
30. Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:451-8.
31. Greenspan D, Komaroff E, Redford M, et al. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 2000; 25:44-50.
32. Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:338-42.
33. Schuman P, Ohmit S, Sobel JD, et al. Oral lesions among women living with or at risk for HIV infection. Am J Med 1998; 104:559-64.
34. Brown KA. Lymphocyte trafficking, survival and proliferation. Trends Immunol 2002; 23:275-7.
35. Schluns KS, Williams K, Ma A, Zheng X, Lefrancois L. Requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002; 168:4827-31.
36. Acevedo GJ, Bascones A, Silva JO. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodont Res 2001; 36:194-203.
37. Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol 2001; 125:134-41.
38. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998; 19:568-74.
39. Garlet G, Martins W Jr, Ferreira BR, Milanezi CM, Silva J. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodont Res 2003; 38:210-7.
40. Traynor TR, Huffnagle GB. Role of chemokines in fungal infections. Med Mycol 2001; 39:41-50.
41. Mahalingam S, Karapiah G. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol 1999; 77:469-75.
42. Sobel JD. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol 1985; 65:435-40.
43. Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans. Oral Microbiol Immunol 1993; 8:313-8.
44. de Repentigny L, Aumont, Ripeau J, et al. Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J Infect Dis 2002; 185:1103-14.